← Back to Search

Imaging Device

OFDI Imaging for Duodenal Inspection

N/A
Waitlist Available
Led By Guillermo Tearney, MD., PhD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subject must be over 18 years for healthy volunteers
Subjects must be over 16 years for patients with Celiac disease
Must not have
Subjects with an inability to swallow pills or capsules
Subjects with a history of intestinal Crohn's disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up images will be acquired during the ofdi imaging session which should on average take anywhere from 30 minutes to 2 hours
Awards & highlights
No Placebo-Only Group

Summary

This trial is being done to see if a tethered capsule, which takes pictures, is tolerable and feasible to use to image the duodenum.

Who is the study for?
This trial is for individuals over 16 with Celiac disease and healthy volunteers over 18, who can swallow pills and give informed consent. It's not for those with Crohn's, fistulas, strictures smaller than the capsule, or pregnant women.
What is being tested?
The study tests a tethered Optical Frequency Domain Imaging (OFDI) capsule to see if it can comfortably and effectively take pictures of the duodenum as it moves through the esophagus into the stomach.
What are the potential side effects?
Potential side effects may include discomfort from swallowing the capsule or minor throat irritation. Since participants are unsedated, sedation risks are avoided.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 years old.
Select...
I am over 16 years old and have Celiac disease.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot swallow pills or capsules.
Select...
I have a history of Crohn's disease affecting my intestines.
Select...
I am currently pregnant.
Select...
I have a narrowing in my esophagus or intestines that is too small for certain medical capsules.
Select...
I have an abnormal connection between my esophagus and intestine.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~images will be acquired during the ofdi imaging session which should on average take anywhere from 30 minutes to 2 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and images will be acquired during the ofdi imaging session which should on average take anywhere from 30 minutes to 2 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Feasibility of OFDI Imaging in subjects swallowing the OFDI capsule
Tolerability of OFDI Imaging in subjects swallowing the OFDI capsule

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: OFDI Capsule ImagingExperimental Treatment1 Intervention
Subject will swallow the OFDI Capsule and imaging will be performed using the OFDI system.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
OFDI Capsule
2013
N/A
~70

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
3,014 Previous Clinical Trials
13,309,323 Total Patients Enrolled
4 Trials studying Celiac Disease
616 Patients Enrolled for Celiac Disease
Guillermo Tearney, MD., PhDPrincipal InvestigatorMassachusetts General Hospital
5 Previous Clinical Trials
209 Total Patients Enrolled

Media Library

OFDI Capsule (Imaging Device) Clinical Trial Eligibility Overview. Trial Name: NCT02202681 — N/A
Celiac Disease Research Study Groups: OFDI Capsule Imaging
Celiac Disease Clinical Trial 2023: OFDI Capsule Highlights & Side Effects. Trial Name: NCT02202681 — N/A
OFDI Capsule (Imaging Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02202681 — N/A
~16 spots leftby Oct 2026